A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment
Conditions
Alagille Syndrome
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Children's Hospital Los Angeles, Los Angeles, California, United States
UCSF Benioff Children's Hospital, San Francisco, California, United States
The Children's Mercy Hospital, Kansas City, Missouri, United States
SSM Health Cardinal Glennon Children's Hospital, St Louis, Missouri, United States
NYU Langone - NYU Grossman School of Medicine, New York, New York, United States
Columbia University Medical Center - Morgan Stanley Children's Hospital of NewYork - Presbyterian (MS-CHONY), New York, New York, United States
Le Bonheur Children's Hospital, Memphis, Tennessee, United States
Children's Medical Center Of Dallas, Dallas, Texas, United States
Proactive El Paso,LLC, El Paso, Texas, United States
Primary Children's Hospital (PCH) - Intermountain Healthcare/University of Utah, Salt Lake City, Utah, United States
Study leads
Ipsen Medical, Director
Study Director
Ipsen